Comparative study of cefpodoxime

3,317 views

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
3,317
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
91
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Comparative study of cefpodoxime

  1. 1. Comparative study of Cefpodoxime and to study the market potential for ’s product portfolio.
  2. 2. Started by Ranbir Singh and Gurbax Singh 1937 Incorporated in 1961 and went public in 1973 June 2008, with Daiichi Sankyo Ranbaxy & Daiichi Sankyo combined rank top 20 global pharmaceutical companies. In public Merger Position No. 1 Indian Pharma Company Global consolidated sales –US $ 1519 Mn (2009) International 77% Domestic 23%
  3. 3. Ginseng Ofloxacin Valacyclovir Ciprofloxacin Diclofenac Amoxycillin Cefpodoxime Atorvastatin Cephalexin Ceftriaxone Isotretinoin Rantidine Imipenem Co-amoxyclav Loratadine Ketorolac Simvastatin
  4. 4.  (Cefpodoxime proxetil) is an orally administered, extended spectrum, semi- syntheticantibiotic of the cephalosporin class.  Microbiology: Cefpodoxime is active against a wide spectrum of Gram-positive and Gram- negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime.  FOR PRODUCT PORTFOLIO ◦ CEPODEM-XP (Cefpodoxime + Clavulanic Acid) ◦ CEROXIM (Cefuroxime) ◦ CEROXIM-XP (Cefuroxime + Clavulanic Acid) ◦ RACIPER (Esomeprazole) ◦ RICONIA (Multivitamin) ◦ ALTRAFLAM (Aceclofenac) ◦ SYNASMA (Doxofylline) ◦ & GEMBAX (Gemifloxacin)
  5. 5. To know the market share of the Ranbaxy’s Products in Ranbaxy (Pharma) Section. To know about the current products that are giving a tough competition to Ranbaxy. To know about the new competitors that have entered into the market and are trying to capture some of it’s share. 1 2 3
  6. 6. Type of Research: Exploratory research Sample unit: Retailer Sample extent: South Delhi Sampling technique: Convenient sampling Sample size: 100 Retailers Data collection methods: Primary methods: (a)Face to face interactions (b) Questionnaire Secondary methods: Company manuals ,Journals ,Magazines & Internet Analysis technique Microsoft Excel has been used for the statistical analysis. Limitations: Sometime respondents refuse to cooperate and it may possible that they give biased and dishonest answers.
  7. 7. SALE OF CEPODEM STRIP/WEEK
  8. 8. 0 10 20 30 40 50 60 70 80 90 CEPODEM CEPODEM-XP CEROXIM CEROXIM-XP RACIPER RICONIA ALTRAFLAM-P SYNASMA GEMBAX Ranbaxy Product sales/week OVERALL AIIMS MALVIYA NAGAR CHITTARANJAN PARK JANGPURA---BHOGAL NEW FRIENDS COLONY JAMIA NAGAR(OKHLA) OKHLA (FORTIS HOSPITAL)
  9. 9. Cost factor Advertisement in medical journals. More profit and replacement schemes to the chemists Availability of products Frequent Doctors Visit.

×